Bio-Rad Laboratories Class A
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell BIO and other ETFs, options, and stocks.About BIO
Bio-Rad Laboratories, Inc. engages in the development, manufacturing, and marketing of a portfolio of instruments, systems, reagents, and consumables. It operates through the following segments: Life Science and Clinical Diagnostics.
BIO Key Statistics
Stock Snapshot
With a market cap of 7.53B, Bio-Rad Laboratories Class A(BIO) trades at $279.25. The stock has a price-to-earnings ratio of 10.03.
On 2026-04-11, Bio-Rad Laboratories Class A(BIO) stock traded between a low of $275.40 and a high of $279.51. Shares are currently priced at $279.25, which is +1.4% above the low and -0.1% below the high.
Bio-Rad Laboratories Class A(BIO) shares are trading with a volume of 234.63K, against a daily average of 300.78K.
In the last year, Bio-Rad Laboratories Class A(BIO) shares hit a 52-week high of $343.12 and a 52-week low of $211.43.
In the last year, Bio-Rad Laboratories Class A(BIO) shares hit a 52-week high of $343.12 and a 52-week low of $211.43.
BIO News
In early April 2026, Citigroup downgraded Bio-Rad Laboratories’ rating from “Buy” to “Neutral,” signaling a shift in analyst sentiment toward the life science a...
Citigroup’s downgrade of Bio-Rad Laboratories (BIO) from Buy to Neutral, along with a sharp cut to its price target, has put fresh attention on how investors as...
Citi analyst Patrick Donnelly downgraded Bio-Rad (BIO) to Neutral from Buy with a price target of $300, down from $375. The firm does not see a recovery path fo...
Analyst ratings
71%
of 7 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.